Benefiting from the gradual re-opening of economies, conditions within the hearing healthcare market have improved and Demant is now operating at a 50-60% sales run rate (vs. 30% in May). Many European countries have seen a progression and the activity level has increased amongst independents. However, as Demant resumes commercial activities and ramps up operations, opex is approaching normalisation faster than revenue – the run rate now at 75-85% (vs. 60% in May) – and thus EBIT
18 Jun 2020
With markets re-opening gradually, Demant’s sales run-rate improves to 50-60%
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
With markets re-opening gradually, Demant’s sales run-rate improves to 50-60%
Benefiting from the gradual re-opening of economies, conditions within the hearing healthcare market have improved and Demant is now operating at a 50-60% sales run rate (vs. 30% in May). Many European countries have seen a progression and the activity level has increased amongst independents. However, as Demant resumes commercial activities and ramps up operations, opex is approaching normalisation faster than revenue – the run rate now at 75-85% (vs. 60% in May) – and thus EBIT